| A Phase 2 Study to Evaluate the Safety and Efficacy of Max-40279-01 in Patients With Advanced Gastric Cancer or Gastroesophageal Junction Cancer (NCT05395780) | Maxinovel Pty., Ltd. | 2022-06-01 |
| Efficacy and Safety of BV With Tislelizumab for the Treatment of CD30+ Relapsed/Refractory NK/T-cell Lymphoma (NCT05316246) | Shanghai Zhongshan Hospital | 2022-06-01 |
| Evaluation of L-PRF as an Antibiotic Slow-release Biological Device in the Treatment of Moderate Periodontitis (NCT06153706) | Yasmeen Khaled | 2022-06-01 |
| Long-Term Follow-Up Study of Patients Receiving ATL001 (NCT04785365) | Achilles Therapeutics UK Limited | 2022-06-01 |
| Intraperitoneal Chemotherapy in Gastric Cancer With Peritoneal Carcinomatosis (NCT05541146) | Instituto do Cancer do Estado de São Paulo | 2022-06-01 |
| Efficacy of Treatment With Pramipexole or Risperidone in Patients With Refractory Obsessive-compulsive Disorder (OCD) (NCT05401019) | Clinical Academic Center (2CA-Braga) | 2022-06-01 |
| Tusamitamab Ravtansine in NSQ NSCLC Participants With Negative or Moderate CEACAM5 Expression Tumors and High Circulating CEA (NCT05245071) | Sanofi | 2022-06-01 |
| Study of Daxdilimab (HZN-7734) for the Treatment of Systemic Lupus Erythematosus in an Open-label Extension Study (NCT05430854) | Amgen | 2022-06-01 |
| Cicletanine in Hypertension With Diabetes: Added Magnesium Preserves Potassium and Sodium (NCT02709031) | Navitas Pharma | 2022-06-01 |
| Azithromycin Versus Doxycycline on Restistin Level in Periodontitis Patients With Type 2 Diabetes (NCT06199440) | King Abdulaziz University | 2022-06-01 |
| Cabo-POLARIS : A Trial to Evaluate Cabozantinib Among Haemodialysied Patients (NCT05241561) | Centre Hospitalier Universitaire de Besancon | 2022-06-01 |
| Pegylated Interferon Alfa-2b Versus Interferon Alfa Therapy in Adult Essential Thrombocythemia (NCT05395507) | Institute of Hematology & Blood Diseases Hospital, China | 2022-06-01 |
| Neoadjuvant TACiE in Locally Advanced Gastric Cancer (NCT05346874) | Shanghai Zhongshan Hospital | 2022-06-01 |
| Zanubrutinib and Eltrombopag as Second-line Treatment in Adults With Primary Immune Thrombocytopenia (NCT05369377) | Peking University People's Hospital | 2022-06-01 |
| A Study of mRNA-3745 in Adult and Pediatric Participants With Glycogen Storage Disease Type 1a (GSD1a) (NCT05095727) | ModernaTX, Inc. | 2022-06-01 |
| Penpulimab Combined With RMA Treatment of Primary Diagnosis of Primary Central Nervous System Lymphoma (NCT05347641) | The First Affiliated Hospital with Nanjing Medical University | 2022-06-01 |
| Modified Foot Exercise to Improve Sensitivity and Perfussion on Type 2 Diabetes Patients (NCT05408234) | Universitas Sebelas Maret | 2022-06-01 |
| Autologous Hematopoietic Stem Cell Transplantation in Pediatric Relapsed or Refractory Hodgkin Lymphoma After Nivolumab Treatment (NCT06931613) | St. Petersburg State Pavlov Medical University | 2022-06-01 |
| A GnRH Agonist IN Pre-menopausal Women STudy to Treat Severe Polycystic Liver Disease (NCT05478083) | University Medical Center Groningen | 2022-06-01 |
| A Study to Evaluate Iloperidone for the Treatment of Parkinson's Disease Psychosis (NCT05344365) | Vanda Pharmaceuticals | 2022-06-01 |
| Atomoxetine and DAW2022 on OSA Severity (NCT05350215) | Brigham and Women's Hospital | 2022-06-01 |
| A Phase II Trial to Explore Niraparib and Anlotinib Maintenance Retreatment in Platinum-Sensitive Recurrent Ovarian Cancer Patients Previously Treated With PARPi (NCT05385068) | Peking Union Medical College Hospital | 2022-06-01 |
| AB8939 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (NCT05211570) | AB Science | 2022-06-01 |
| Rituximab in Patients With ST-elevation Myocardial Infarction (NCT05211401) | Assistance Publique - Hôpitaux de Paris | 2022-06-01 |
| A Study of DZD8586 in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (TAI-SHAN1) (NCT05844956) | Dizal Pharmaceuticals | 2022-06-01 |
| Evaluating the Effect of Mirtazapine on Anxiety in Parkinson's Disease Patients (NCT06530290) | Leila Dargahi. PharmD PhD | 2022-06-01 |
| Efficacy of EGF-loaded Self Healing Gel in Treatment of Oral Mucositis (NCT04995354) | Cairo University | 2022-06-01 |
| Study of Neoadjuvant Nivolumab or Placebo Plus Chemotherapy Followed by Surgery and Adjuvant Treatment in Subjects With Resectable ESCC (NCT05213312) | Shanghai Zhongshan Hospital | 2022-06-01 |
| TOPAZ: Tucatinib in COmbination With Pembrolizumab And TrastuZumab in Patients With HER2-Positive Breast Cancer Brain Metastases (NCT04512261) | Reva Basho | 2022-06-01 |
| Long Acting Buprenorphine Injection Compared to Sublingual Buprenorphine/Naloxone Films (NCT03744663) | Wake Forest University Health Sciences | 2022-06-01 |
| A Trial of Guanfacine-er for Cannabis Use Disorder (NCT05273567) | New York State Psychiatric Institute | 2022-06-01 |
| Effect of Epidural Hydromorphone Combined With Ropivacaine in Labor Analgesia (NCT05901441) | Maternal and Child Health Hospital of Hubei Province | 2022-06-01 |
| The Efficacy and Safety of Dalpiciclib Plus Endocrine Therapy in HR-positive / HER2-negative Advanced Breast Cancer Patients With Visceral Crisis (NCT05431504) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2022-06-01 |
| The BeLimumab Antiphospholipid Syndrome Trial (BLAST) (NCT05020782) | University of Turin, Italy | 2022-06-01 |
| A Study of QL1706 Combined With Chemotherapy in Advanced Non-small Cell Lung Cancer (NCT05329025) | Qilu Pharmaceutical Co., Ltd. | 2022-06-01 |
| Bladder Sparing Treatment of Tislelizumab, Gemcitabine and Cisplatin for Patients With PD-L1 Positive Muscle Invasive Bladder Cancer (NCT05401279) | RenJi Hospital | 2022-06-01 |
| A Clinical Study of Herombopag in Tumors-associated Thrombocytopenia (NCT05350956) | The First Affiliated Hospital of Zhengzhou University | 2022-06-01 |
| A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZYIL1 in Subjects With Cryopyrin Associated Periodic Syndromes (CAPS) (NCT05186051) | Zydus Lifesciences Limited | 2022-06-01 |
| Phase II Trial to Evaluate Safety and Efficacy of GM-CSF/Sargramostim in Alzheimer's Disease (NCT04902703) | University of Colorado, Denver | 2022-06-01 |
| LGG Supplementation in Patients With AUD and ALD (NCT05178069) | University of Louisville | 2022-06-01 |
| Tislelizumab +Bevacizumab+pc for Untreated EGFR+ and High PD-L1 Non-squamous NSCLC (NCT05394233) | Sichuan Cancer Hospital and Research Institute | 2022-06-01 |
| HER2-positive Breast Cancer Project Initiated by Investigators (NCT05346328) | Fudan University | 2022-06-01 |
| Comparison of Antimicrobial Action of Sodium Hypochlorite and Polyhexamethylene Biguanide as Root Canal Irrigants (NCT05306431) | Altamash Institute of Dental Medicine | 2022-06-01 |
| Topical Insulin Drops for the Treatment of Neurotrophic Keratopathy. (NCT05321251) | University of Alberta | 2022-06-01 |
| KurCoSmart Effects on People With Type 2 DM (NCT05407467) | Universitas Sebelas Maret | 2022-06-01 |
| Axitinib +/- Pembrolizumab in First Line Treatment of mPRCC (NCT05096390) | Centre Leon Berard | 2022-06-01 |
| Reduced MBF Regimen for Patients >=55 Years With Myeloid Malignancies (NCT05436561) | Shanghai Jiao Tong University School of Medicine | 2022-06-01 |
| Pilot Decentralized Trial (NCT05419869) | Alto Neuroscience | 2022-06-01 |
| Salvage Surgery Following Downstaging of Advanced Non-small Cell Lung Cancer by Targeted Therapy (SDANT) (NCT05085054) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2022-06-01 |
| Optimizing Pembrolizumab Therapy With Timing and Intensification With Axitinib (NCT05263609) | University of Oklahoma | 2022-06-01 |
| Ketamine Infusion for Rapid Reduction of Suicidality in Pediatrics (NCT04955470) | University of British Columbia | 2022-06-01 |
| A Pilot Study of Antioxidant Therapy in Obstructive Sleep Apnea Patients (NCT05009901) | University of British Columbia | 2022-06-01 |
| Efficacy of Reboxetine and Methylphenidate Treatment on Attentional, Sensory and Emotional Dysregulation in Adults With PTSD (NCT05133804) | University of Haifa | 2022-06-01 |
| Baricitinib for Cutaneous Dermatomyositis (NCT05361109) | University of Washington | 2022-06-01 |
| Fruquintinib Combined With Toripalimab and SOX Regimen in the First-line Treatment of Advanced Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma (NCT05024812) | The First Affiliated Hospital of Zhengzhou University | 2022-06-01 |
| Medications After Adolescent Bariatric Surgery (NCT04572217) | Janey Pratt | 2022-06-01 |
| Roflumilust in Chronic Rhinosinusitis With Nasal Polyposis. (NCT05369039) | Menoufia University | 2022-06-01 |
| INcobotulinumtoxina in ChIldren Upper and Lower Limb sPasticITy (INCIPIT) (NCT05340439) | Universita di Verona | 2022-06-01 |
| Budesonide Multimatrix(MMX) Versus Prednisolone in Management of Mild to Moderate Ulcerative Colitis (NCT05341401) | Assiut University | 2022-06-01 |
| A Phase IIb, Multi-Center, Multinational, Double-Blind, Placebo-Controlled Study, With an Open Label Extension, to Evaluate Safety, Tolerability and Efficacy of PrimeC in Subjects With ALS (NCT05357950) | NeuroSense Therapeutics Ltd. | 2022-05-31 |
| Phase 1/2 Study of CD19 Chimeric Antigen Receptor T-cell (CD19 CAR-T; PL001) for Relapsed or Refractory B-cell Lymphoma (NCT05326243) | Pell Bio-Med Technology Co., Ltd. | 2022-05-31 |
| Induction Tislelizumab Combined With Chemotherapy Followed by Definitive Chemoradiotherapy in the Treatment of Locally Unresectable Esophageal Squamous Cell Carcinoma (NCT05515315) | Fuzhou General Hospital | 2022-05-31 |
| MARVEL: Mitochondrial Anti-oxidant Therapy to Resolve Inflammation in Ulcerative Colitis (NCT04276740) | University of Edinburgh | 2022-05-31 |
| Erenumab-aooe for the Management of Trigeminal Neuropathic Pain. (NCT05142228) | University of Maryland, Baltimore | 2022-05-31 |
| Phase II Study of Salvage Radiation Treatment After B-cell Maturation Antigen Chimeric Antigen Receptor T-cell Therapy for Relapsed Refractory Multiple Myeloma (NCT05336383) | M.D. Anderson Cancer Center | 2022-05-31 |
| Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS (NCT05379985) | Revolution Medicines, Inc. | 2022-05-31 |
| A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG) (NCT05099003) | National Cancer Institute (NCI) | 2022-05-31 |
| Osimertinib With or Without Savolitinib as 1L in de Novo MET+, EGFR+ NSCLC (NCT05163249) | Guangdong Association of Clinical Trials | 2022-05-31 |
| Improving Cerebral Blood Flow and Cognition in Patients with Cerebral Small Vessel Disease. the ETLAS-2 Trial (NCT05173896) | Christina Kruuse | 2022-05-31 |
| Study of Oral High/Low-dose Cepharanthine Compared With Placebo in Non Hospitalized Adults With COVID-19 (NCT05398705) | Shanghai Jiao Tong University School of Medicine | 2022-05-31 |
| Atomoxetine in Patients With Tourette's Syndrome (NCT04354103) | Poitiers University Hospital | 2022-05-31 |
| Early Administration of Insulin Glargine in Patients With Diabetic Ketoacidosis (NCT06007508) | HealthPartners Institute | 2022-05-31 |
| AZD4205 in Relapsed or Refractory Peripheral T Cell Lymphoma (JACKPOT27) (NCT06511895) | Dizal Pharmaceuticals | 2022-05-31 |
| RESPIRARE - Efficacy and Safety of Cudetaxestat in Patients With Idiopathic Pulmonary Fibrosis (IPF) (NCT05373914) | Blade Therapeutics | 2022-05-31 |
| ACCENT: AMP945 in Combination With Nab-paclitaxel and Gemcitabine for Treatment of Pancreatic Cancer (NCT05355298) | Amplia Therapeutics Limited | 2022-05-31 |
| Testing the Addition of Paclitaxel and Carboplatin Given After Standard Chemotherapy and Radiation for Cervical Cancer in HIV-positive Women (NCT03834571) | AIDS Malignancy Consortium | 2022-05-31 |
| A Phase I/II Study to Evaluate the Safety, Pharmacokinetics and Efficacy of PRJ1-3024 in Subjects with Advanced Solid Tumors (NCT05315167) | Zhuhai Yufan Biotechnologies Co., Ltd | 2022-05-30 |
| Antimicrobial Photodynamic Therapy as an Adjunct for Management of Deep Caries Lesions (NCT05236205) | University of Nove de Julho | 2022-05-30 |
| Immunogenicity and Safety Study of Recombinant Two-Component COVID-19 Vaccine (CHO Cell)(ReCOV) (NCT05323435) | Jiangsu Rec-Biotechnology Co., Ltd. | 2022-05-30 |
| Sotorasib in Advanced KRASG12C-mutated Non-small Cell Lung Cancer Patients With Comorbidities (NCT05311709) | Vestre Viken Hospital Trust | 2022-05-30 |
| Atezolizumab Immunotherapy, in Immunotherapy Naive Patients With Urinary Tract Squamous Cell Carcinoma (UTSCC). (NCT05038657) | University Hospital Southampton NHS Foundation Trust | 2022-05-30 |
| GPL in Patients with Relapsed/refractory Diffuse Large B Cell Lymphoma (NCT05335018) | Seoul National University Hospital | 2022-05-30 |
| CardioPulmonary Resuscitation With Argon (CPAr) Trial (NCT05482945) | Mario Negri Institute for Pharmacological Research | 2022-05-30 |
| PSMA-PET/CT to Assess the Expression of Specific Membrane Antigen (PSMA) in Patients With Progressive Triple-negative Breast Cancer. (NCT06059469) | Jules Bordet Institute | 2022-05-30 |
| A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis (NCT05076175) | Bristol-Myers Squibb | 2022-05-30 |
| TACE/HAIC Combined With Lenvatinib and Sintilimab in Neoadjuvant Therapy for Intermediate-stage HCC (NCT05250843) | Third Affiliated Hospital, Sun Yat-Sen University | 2022-05-30 |
| S-531011 as Monotherapy and in Combination With an Immune Checkpoint Inhibitor in Advanced or Metastatic Solid Tumors (NCT05101070) | Shionogi | 2022-05-30 |
| Combination of Conditioned Medium and Umbilical Cord-Mesenchymal Stem Cells Therapy for Acute Stroke Infarct (NCT05008588) | PT. Prodia Stem Cell Indonesia | 2022-05-30 |
| Study of Sacituzumab Govitecan Combinations in First-line Treatment of Participants With Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC) (NCT05186974) | Gilead Sciences | 2022-05-30 |
| Preoperative Short Course Radiotherapy With Envafolimab, Endostatin and SOX Regimen in Locally Advanced Gastric (NCT05387681) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2022-05-30 |
| A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFICACY OF SHR-A1904 IN SUBJECTS WITH ADVANCED SOLID TUMORS (NCT05277168) | Jiangsu HengRui Medicine Co., Ltd. | 2022-05-30 |
| Jafron Haemoadsorption During Cardiopulmonary Bypass (NCT05349669) | Anthea Hospital Bari | 2022-05-30 |
| Efficacy and Safety of Chidamide Combined With BEAM Pretreatment Regimen in Autologous Transplantation for T-cell Lymphoma (NCT05367856) | Ruijin Hospital | 2022-05-28 |
| Lipiodol-TACE With Idarubicin for Hepatocellular Carcinoma (NCT05280444) | Zhongda Hospital | 2022-05-28 |
| AsiDNA Children, Adolescents and Young Adults (NCT05394558) | Institut Curie | 2022-05-27 |
| Cetuximab for the Treatment of Advanced Unresectable or Metastatic Chordoma (NCT05041127) | M.D. Anderson Cancer Center | 2022-05-27 |
| A Study of PM8002 in Combination With Chemotherapy in Patients With SCLC (NCT05879068) | Biotheus Inc. | 2022-05-27 |
| Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer (NCT05168163) | Academic and Community Cancer Research United | 2022-05-27 |
| Durvalumab With Carboplatin and Etoposide Chemotherapy in Pulmonary Large-cell Neuroendocrine Carcinoma (LCNEC) (NCT06418087) | Gruppo Oncologico Italiano di Ricerca Clinica | 2022-05-27 |
| Phase I Trial of GR1803 Injection in Patients With RRMM (NCT07102706) | Genrix (Shanghai) Biopharmaceutical Co., Ltd. | 2022-05-27 |